Find Reports

Select Report Type

Reimbursement Review

Displaying 801 - 825 of 1426

Please scroll or swipe to the right to view the full content.

Title	Brand Name	Generic Name	Files	Therapeutic Area	Recommendation Type	Status	Submission Date	Recommendation Date Sort ascending	Project Number
Somatropin	Genotropin	Somatropin	cdr_SR0334_Genotropin_TS.pdf SR0334_GenotropinTS_CL_Report_e.pdf SR0334_GenotropinTS_PE_Report_e.pdf SR0334_complete_Genotropin-TS_Dec-23-13.pdf	Turner Syndrome	List with criteria/condition	Complete	May 27, 2013	Dec 20, 2013	SR0334-000
Ocriplasmin	Jetrea	Ocriplasmin	cdr_SR0337_Jetrea.pdf SR0337_Jetrea_CL_Report_e.pdf SR0337_Jetrea_PE_Report_e.pdf SR0337_complete_Jetrea_Dec-23-13.pdf	Vitreomacular adhesion	List with criteria/condition	Complete	Jun 6, 2013	Dec 20, 2013	SR0337-000
Adcetris for systemic Anaplast...	Adcetris	Brentuximab vedotin	pcodr-provfund_adcetris-salcl.pdf pcodr-adcetris-salcl-fn-rec.pdf pcodr-adcetris-salcl-fn-cgr.pdf pcodr-adcetris-salcl-fn-egr.pdf pcodr-adcetris-salcl-in-rec.pdf pcodr-adcetris-salcl-pagfdk.pdf pcodr-adcetris-salcl-coi-lfc.pdf	Systemic Anaplastic Large Cell Lymphoma	Reimburse with clinical criteria and/or conditions	Complete	Mar 15, 2013	Dec 5, 2013	PC0021-000
Tafinlar for Metastatic Melano...	Tafinlar	Dabrafenib	pcodr-provfund_tafinlar-metmel.pdf pcodr-tafinlar-metmla-fn-rec.pdf pcodr-tafinlar-metmla-fn-cgr.pdf pcodr-tafinlar-metmla-fn-egr.pdf pcodr-tafinlar-metmla-in-rec.pdf pcodr-tafinlar-pag-fdk-in-rec.pdf pcodr-tafinlar-in-fdk-gsk.pdf pcodr-tafinlar-ptfdk-mnc.pdf pcodr-tafinlar-coi-mnc.pdf pcodr-tafinlar-ptfdk-sysf.pdf pcodr-tafinlar-coi-sysf.pdf	Metastatic Melanoma	Reimburse with clinical criteria and/or conditions	Complete	Mar 18, 2013	Dec 5, 2013	PC0025-000
Pemetrexed Alimta for Advanced...	Alimta	Pemetrexed	pcodr_provfund_alimta-nsclc.pdf pcodr-alimta-ns-nsclc-fn-rec.pdf pcodr-alimta-ns-nsclc-fn-cgr.pdf pcodr-alimta-ns-nsclc-fn-egr.pdf pcodr-alimta-ns-nsclc-in-rec.pdf pcodr-alimta-pagfdk-inrec.pdf pcodr-alimta-infdk-elilc.pdf pcodr-alimta-coi-ccsn.pdf pcodr-alimta-coi-lcc.pdf	Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer	Reimburse with clinical criteria and/or conditions	Complete	May 31, 2013	Nov 19, 2013	PC0027-000
Ulipristal acetate	Fibristal	Ulipristal acetate	cdr_SR0326_Fibristal.pdf SR0326_Fibristal_CL_Report_e.pdf SR0326_Fibristal_PE_Report_e.pdf complete_SR0326_Fibristal_19-Nov-13_e.pdf	Uterine fibroids	List with criteria/condition	Complete	Apr 17, 2013	Nov 15, 2013	SR0326-000
Saxagliptin	Onglyza	Saxagliptin	Recommendation and Reasons: Updated Submission Status Report Recommendation and Reasons: Original Clinical Report Pharmacoeconomic Report	Diabetes mellitus, type 2	List with criteria/condition	Complete	May 9, 2013	Nov 15, 2013	SR0329-000
Stivarga for Metastatic Colore...	Stivarga (CRC)	Regorafenib	pcodr_provfund_stivarga-mcrc.pdf pcodr-stivargamcrc-fn-rec.pdf pcodr-stivargamcrc-fn-cgr.pdf pcodr-stivargamcrc-fn-egr.pdf pcodr-stivargamcrc-in-rec.pdf pcodr-stivarga-mcrc-pagfdk-inr.pdf pcodr-stivarga-mcrc-fdk-bayer.pdf pcodr-stivarga-mcrc-ptfdk-ccac.pdf pcodr-stivarga-mcrc-coi-ccac.pdf	Metastatic Colorectal Cancer	Do not reimburse	Complete	Mar 22, 2013	Nov 15, 2013	PC0026-000
Zytiga for Metastatic Castrati...	Zytiga	Abiraterone acetate	pcodr_profund_abiraterone_zytiga_mcrpc.pdf pcodr-zytiga-mcrpc-fn-rec.pdf pcodr-zytiga-mcrpc-fn-cgr.pdf pcodr-zytiga-mcrpc-fn-egr.pdf pcodr-zytiga-mcrpc-in-rec.pdf pcodr-zytiga-pag-fdk-in-rec.pdf pcodr-zytiga-in-fdk-janssen.pdf pcodr-zytiga-in-fdk-ccsn.pdf pcodr-zytiga-coi-ccsn.pdf pcodr-zytiga-in-fdk-pcc.pdf pcodr-zytiga-coi-pcc.pdf	Metastatic Castration Resistant Prostate Cancer	Reimburse with clinical criteria and/or conditions	Complete	Mar 28, 2013	Oct 22, 2013	PC0028-000
Mekinist for Metastatic Melano...	Mekinist	Trametinib	pcodr_provfund_mekinist-metmel.pdf pcodr-mekinist-mm-fn-rec.pdf pcodr-mekinist-metmela-fn-cgr.pdf pcodr-mekinist-metmela-fn-egr.pdf pcodr-mekinist-metmela-in-rec.pdf pcodr-mekinist-pag-fdk-in-rec.pdf pcodr-mekinist-in-fdk-gsk.pdf pcodr-mekinist-in-fdk-mnc.pdf pcodr-mekinist-coi-mnc.pdf	Metastatic Melanoma	Reimburse with clinical criteria and/or conditions	Complete	May 6, 2013	Oct 22, 2013	PC0030-000
Revlimid for Multiple Myeloma ...	Revlimid	Lenalidomide	pcodr_provfund_revlimid-mm.pdf pcodr-revlimid-mm-fn-rec.pdf pcodr-revlimid-mm-fn-cgr.pdf pcodr-revlimid-mm-fn-egr.pdf pcodr-revlimid-mm-in-rec.pdf pcodr-revlimid-pag-fdk-in-rec.pdf pcodr-revlimid-in-fdk-celgene.pdf pcodr-revlimid-coi-mc.pdf	Multiple Myeloma (as maintenance therapy)	Reimburse with clinical criteria and/or conditions	Complete	Apr 5, 2013	Oct 22, 2013	PC0029-000
Perampanel	Fycompa	Perampanel	cdr_SR0316_Fycompa.pdf cdr_complete_Fycompa_October-21-13_e.pdf	Epilepsy, partial onset seizures	List with criteria/condition	Complete	Mar 8, 2013	Oct 17, 2013	SR0316-000
Azilsartan medoxomil	Edarbi	Azilsartan medoxomil	cdr_SR0317_Edarbi.pdf cdr_complete_Edarbi_October-21-13_e.pdf	Hypertension	Do not list at the submitted price	Complete	Mar 8, 2013	Oct 17, 2013	SR0317-000
Azilsartan medoxomil + chlorth...	Edarbyclor	Azilsartan medoxomil + chlorthalidone	cdr_SR0318_Edarbyclor.pdf cdr_complete_Edarbyclor_October-21-13_e.pdf	Hypertension	Do not list	Complete	Mar 8, 2013	Oct 17, 2013	SR0318-000
Linagliptin-metformin	Jentadueto	Linagliptin-metformin	Recommendation and Reasons: Updated Submission Status Report Recommendation and Reasons: Original	Diabetes mellitus, type 2	List with criteria/condition	Complete	Mar 8, 2013	Oct 17, 2013	SR0306-000
Zolpidem tartrate	Sublinox	Zolpidem tartrate	cdr_SR0314_Sublinox.pdf cdr_complete_Sublinox_September_27_13.pdf	Insomnia	Do not list	Complete	Mar 7, 2013	Sep 25, 2013	SR0314-000
Dimethyl fumarate	Tecfidera	Dimethyl fumarate	cdr_SR0309_Tecfidera.pdf cdr_complete_Tecfidera_September_30-13.pdf	Multiple sclerosis, relapsing-remitting	List with criteria/condition	Complete	Feb 4, 2013	Sep 25, 2013	SR0309-000
Everolimus	Afinitor	Everolimus	cdr_SR0315_Afinitor.pdf cdr_compete_Afinitor_September_27_13.pdf	Renal angiomyolipoma associated with tuberous sclerosis complex (TSC)	Do not list	Complete	Mar 8, 2013	Sep 25, 2013	SR0315-000
Votrient for metastatic renal ...	Votrient	Pazopanib hydrochloride	pcodr-provfund_votrientmrcc-re.pdf pcodr-votrientmrccre-fn-rec.pdf pcodr-votrientmrccre-fn-cgr.pdf pcodr-votrientmrccre-fn-egr.pdf pcodr-votrientmrccre-in-rec.pdf pcodr-votrientmrccre-pag-fdbk.pdf pcodr-votrientmrccre-infdk-gsk.pdf pcodr-votrientmrccre-ptfdk-kcc.pdf pcodr-votrientmrccre-coi-kcc.pdf	Metastatic Renal Cell Carcinoma	Reimburse	Complete	Feb 20, 2013	Aug 29, 2013	PC0022-000
Adcetris for Hodgkin Lymphoma ...	Adcetris	Brentuximab vedotin	pcodr-provfund_adcetris-hl.pdf pcodr-adcetrishl-fn-rec.pdf pcodr-adcetrishl-fn-cgr.pdf pcodr-adcetrishl-fn-egr.pdf pcodr-adcetrishl-in-rec.pdf pcodr-adcetrishl-pag-fdk-inrec.pdf pcodr-adcetrishl-in-fdk-sg.pdf pcodr-adcetrishl-pt-fdk-lfc.pdf pcodr-adcetrishl-coi-lfc.pdf	Hodgkin Lymphoma	Reimburse with clinical criteria and/or conditions	Complete	Mar 14, 2013	Aug 29, 2013	PC0020-000
Interferon beta-1a	Rebif	Interferon beta-1a	cdr_SR0298_Rebif.pdf cdr_complete_Rebif_Aug-19-13.pdf	Clinically isolated syndrome	Do not list	Complete	Mar 8, 2013	Aug 15, 2013	SR0298-000
Perjeta for Metastatic Breast ...	Perjeta Herceptin Combo Pack	Pertuzumab	pcodr_profund_pertuzumab_perjeta_mbc.pdf pcodr-perjetacp-mbc-fn-rec.pdf pcodr-perjetacp-mbc-fn-cgr.pdf pcodr-perjetacp-mbc-fn-egr.pdf pcodr-perjetacp-mbc-in-rec.pdf pcodr-perjetacp-pag-fdk-in-rec.pdf pcodr-perjetacp-mbc-in-fdk-hlr.pdf pcodr-perjetacp-mbc-coi-cbcn.pdf pcodr-perjetacp-mbc-coi-rethin.pdf	Metastatic Breast Cancer	Reimburse with clinical criteria and/or conditions	Complete	Nov 2, 2012	Aug 1, 2013	PC0018-000
Xtandi for metastatic Castrati...	Xtandi	Enzalutamide	pcodr_profund_enzalutamide_xtandi_mcrpc.pdf pcodr-xtandi-fn-rec.pdf pcodr-xtandi-mcrpc-fn-cgr.pdf pcodr-xtandi-mcrpc-fn-egr.pdf pcodr-xtandi-mcrpc-in-rec.pdf pcodr-xtandi-pag-fdk-in-rec.pdf pcodr-xtandi-in-fdk-astellas.pdf pcodr-xtandi-coi-pcc.pdf pcodr-xtandi-coi-ccsn.pdf	Metastatic Castration Resistant Prostate Cancer	Reimburse with clinical criteria and/or conditions	Complete	Mar 4, 2013	Jul 23, 2013	PC0023-000
Dabigatran etexilate	Pradaxa	Dabigatran etexilate	cdr_SF0320_Pradaxa_SPAF_RfA.pdf cdr_complete_Pradaxa-SPAF-RfA_July-22-13_e.pdf	Atrial fibrillation prevention of stroke and systemic embolism	List with clinical criteria and/or conditions	Complete	Mar 18, 2013	Jul 18, 2013	SF0320-000
Rivaroxaban	Xarelto	Rivaroxaban	cdr_SF0321_Xarelto_SPAF_RfA.pdf cdr_complete_Xarelto-SPAF-RfA_July-22-13_e.pdf		List with clinical criteria and/or conditions	Complete	Mar 18, 2013	Jul 18, 2013	SF0321-00

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 601 - 602 of 602

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 110 of 110

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 27 of 27

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 801 - 825 of 2138

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
Health Technology Assessment Recommendations and Managed Entry Agreements Related to Optimizing the Treatment for Pediatric Spinal Muscular Atrophy		Aug 17, 2022	Health Technology Review	Environmental Scan	In Progress	ES0368-000
Virtual Care Use in Primary Care or Specialty Care Settings	Virtual Care Use in Primary Care or Specialty Care Settings In-Brief Guidelines for use of virtual care in primary care or specialty care s…	Aug 17, 2022	Health Technology Review	Rapid Review	Completed	RC1444-000
Concurrent or Sequential Administration of Drugs for COVID-19 and Influenza	Concurrent or Sequential Administration of Drugs for COVID-19 and Influenza	Aug 15, 2022	Health Technology Review	Rapid Review	Completed	RC1446-000
Liposuction for Lipedema: A 2022 Update	Liposuction for Lipedema: 2022 Update	Aug 12, 2022	Health Technology Review	Rapid Review	Completed	RC1447-000
ospemifene	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Aug 11, 2022	Reimbursement Review		Complete	SR0709-000
Mesalamine for the Treatment of Crohn Disease	Mesalamine for the Treatment of Crohn’s Disease	Aug 10, 2022	Health Technology Review	Rapid Review	Completed	RC1445-000
An Overview of Comprehensive Genomic Profiling Technologies to Inform Cancer Care	An Overview of Comprehensive Genomic Profiling Technologies to Inform Cancer Ca…	Aug 10, 2022	Horizon Scan	Emerging Health Technologies	Completed	EH0106-000
Understanding the Portrait of Dementia Care in Canada: Our Panel of Experts	Understanding the Portrait of Dementia Care in Canada: Our Panel of Experts	Aug 10, 2022	Horizon Scan	Emerging Health Technologies	Completed	EH0110-000
immune globulin human and recombinant human hyaluronidase	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Patient Group Input Submission Stakeholder feedback on Draft Recommendation	Aug 10, 2022	Reimbursement Review		Complete	ST0695-000
NSCLC without actionable oncogenic alterations	Final Report	Aug 5, 2022	Reimbursement Review	Provisional Funding Algorithm	Complete	PH0012-000
Post-COVID-19 Condition: A summary of existing guidelines	Post-COVID-19 Condition: A summary of existing guidelines	Aug 4, 2022	Health Technology Review	Technology Review	Complete	HC0037-000
Kisqali for Advanced or Metastatic Breast Cancer – Details	RibociclibKisqali_MBC10194ProvFunding.pdf 10194RibociclibMBC_FnRec_Chair Approved_Post04Jun2020_final.pdf 10194RibociclibMBC_fnEGR_NOREDACT-ABBREV_Post04Jun2020_final.pdf 10194RibociclibMBC_fnCGR_NOREDACT_Post04Jun2020_final.pdf 10194RibociclibMBC_inRec_pERC Chair Approved_Post02Apr2020_final.pdf 10194RibociclibMBC_PAGFeedbackSummary_Post04Jun2020_final.pdf 10194RibociclibMBC_SponsorFeedback_Post04Jun2020_final.pdf 10194RibociclibMBC_Combined_PatientFeedback_Post04Jun2020_final_Redacted.pdf 10194RibociclibMBC_ClinicianFeedback_CCO_Post04Jun2020_final_Redacted.pdf 10194RibociclibMBC_Combined COI_Redacted.pdf 10194RibociclibMBC_Clinician Combined COI_Redacted.pdf	Aug 4, 2022	Reimbursement Review		Complete	PC0194-000
Tecentriq for Small Cell Lung Cancer	10156AtezolizumabSCLC_FnRec_ProceduralReview_approvedbyChair_Post_30Jan2020_final.pdf 10156AtezolizumabSCLC_fnEGR_NOREDACT-ABBREV_Post_30Jan2020_final.pdf 10156AtezolizumabSCLC_fnCGR_REDACT_Post_30Jan2020_final.pdf 10156AtezolizumabSCLC_InRec_approvedbyChair_Post_03Oct2019_final.pdf 10156AtezolizumabSCLC_PAGFeedbackSummary_2019-10-11_Post_05Dec2019_final.pdf 10156AtezolizumabSCLC_SponsorFeedback_2019-10-18_Post_05Dec2019_final.pdf 10156AtezolizumabSCLC_PatientFeedback_Combined_Post_05Dec2019_final.pdf 10156AtezolizumabSCLC_ClinicianFeedback_Combined_Post_05Dec2019_final.pdf 10156AtezolizumabSCLC_Combined_Patient_COI_Post_05Dec2019_final_Redacted.pdf 10156AtezolizumabSCLC_Combined COIs_Post_05Dec2019_final_Redacted.pdf	Aug 3, 2022	Reimbursement Review		Complete	PC0156-000
Portable Bone Imaging Devices for Screening and Diagnosing Osteoporosis	Portable Bone Imaging Devices for Screening and Diagnosing Osteoporosis	Aug 2, 2022	Health Technology Review	Rapid Review	Completed	RC1438-000
Models of Care for People Re-Entering the Community After Incarceration	Models of Care for People Re-Entering the Community After Incarceration	Aug 2, 2022	Health Technology Review	Technology Review	Completed	HC0039-000
Low-Dose Ipilimumab in Combination With Nivolumab or Pembrolizumab for the Treatment of Advanced Melanoma	Low-Dose Ipilimumab in Combination With Nivolumab or Pembrolizumab for the Trea…	Aug 2, 2022	Health Technology Review	Rapid Review	Completed	RC1441-000
Interventions for the treatment of obstructive sleep apnea: economic update		Jul 29, 2022	Health Technology Review	Technology Review	In Progress	HE0038-000
Guanfacine for Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and/or Oppositional Defiance Disorder	Guanfacine for Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disord…	Jul 27, 2022	Health Technology Review	Rapid Review	Completed	RC1440-000
Acalabrutinib (Calquence) for chronic lymphocytic leukemia - Details	10211AcalabrutinibCLL_fnRec_REDACT_EC_Post17Nov2020_final.pdf 10211AcalabrutinibCLL_fnEGR_REDACTABBREV_EC_Post17Nov2020_final.pdf 10211AcalabrutinibCLL_fnCGR_REDACT_EC_Post17Nov2020_final_v2.pdf 10211AcalabrutinibCLL_inRec_pERC Chair Approved_REDACT_Post29Oct2020_final.pdf 10211AcalabrutinibCLL_PAGFeedbackSummary_EC_Post17Nov2020_final.pdf 10211AcalabrutinibCLL_SponsorFeedback_EC_Post_17Nov2020_final.pdf 10211AcalabrutinibCLL_PatientFeedback_CLLPAG_EC_Post17Nov2020_final.pdf 10211AcalabrutinibCLL_ClinicianFeedback_CCO_EC_Post17Nov2020_final.pdf 10211AcalabrutinibCLL_COIs_EC_Post17Nov2020_final.pdf 10211AcalabrutinibCLL_Combined Clinician COIs_EC_Post17Nov2020_final_Redacted.pdf	Jul 27, 2022	Reimbursement Review		Complete	PC0211-000
Multiple Prosthetic Sockets for Lower Limb Amputations	Multiple Prosthetic Sockets for Lower Limb Amputations	Jul 21, 2022	Health Technology Review	Rapid Review	Completed	RC1439-000
Autologous Hematopoietic Stem Cell Transplant for People With Multiple Sclerosis	HTERP Guidance Statement – AHSCT for treatment of Multiple Sclerosis Horizon Scan - Bulletin	Jul 20, 2022	Horizon Scan	Optimal Use	Complete	EH0093 / OP0551
Improving Access to Primary Care in Canada	Improving Access to Primary Care in Canada	Jul 19, 2022	Health Technology Review	Environmental Scan	Completed	ES0363-000
Diacetylmorphine for Adults With Opioid Dependence	Diacetylmorphine for Adults With Opioid Dependence	Jul 18, 2022	Health Technology Review	Rapid Review	Completed	RC1437-000
Trace Amine-Associated Receptor 1 Agonists for Schizophrenia	Trace Amine-Associated Receptor 1 Agonists for Schizophrenia	Jul 15, 2022	Horizon Scan	Emerging Health Technologies	Completed	EH0105-000
fostamatinib	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Patient Group Input Submissions Stakeholder feedback on Draft Recommendation	Jul 13, 2022	Reimbursement Review		Complete	SR0701-000

Provisional Funding Algorithm

Displaying 76 - 81 of 81